GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Float Percentage Of Total Shares Outstanding

Veracyte (FRA:12V) Float Percentage Of Total Shares Outstanding : 86.82% (As of May. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Veracyte Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Veracyte's float shares is 66.37 Mil. Veracyte's total shares outstanding is 76.45 Mil. Veracyte's float percentage of total shares outstanding is 86.82%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Veracyte's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Veracyte's Institutional Ownership is 88.88%.

Veracyte Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Veracyte's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=66.37/76.45
=86.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte (FRA:12V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Veracyte Inc (FRA:12V) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
BEAM PTCT SWTX SMMT PNT RYTM IDYA VCEL CPRX ACLX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VCYT:USA
Address
6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Website
https://www.veracyte.com
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.

Veracyte (FRA:12V) Headlines

No Headlines